Nephrology / Dialysis

Dialysis management, CKD monitoring, and renal replacement therapy

Gopal Mehta (ICU) — AKI: eGFR 8, oliguria. CRRT running. K 5.8 — restrict dietary potassium. Await meropenem dose adjustment.

Sushila Mehta, 82F

Hypertensive nephrosclerosis · CKD G5D (Dialysis)

Haemodialysis (HD)
Access: Right AVF — functioning (flow 350 mL/min)
Schedule: Mon/Wed/Fri — 4h sessions
Last Session: 22 Jun 2026 — Kt/V 1.4, UF 2.1L, BP post: 130/80
Current Issues: K 5.8 (hyperkalaemia — dietary counselling given). HCO₃ 16 — acidosis. Iron deficiency (ferritin 42). EPO dose increased.
Continue HD 3×/week. Low-potassium diet reinforcement. IV Iron sucrose. Cinacalcet 30 mg OD for sHPT (PTH 820). Renal transplant evaluation — cardiology clearance pending.

Gopal Mehta, 45M

Diabetic nephropathy · CKD G5

CRRT (CVVHDF)
Access: Right femoral temporary catheter (VasCath)
Schedule: Continuous — ICU
Last Session: Ongoing — 22 Jun 2026
Current Issues: AKI on CKD — eGFR 8 (baseline 14). Oliguria (300 mL/day). Sepsis (ESBL Klebsiella). Fluid overload +4L.
Continue CRRT CVVHDF at 35 mL/kg/h until haemodynamically stable. Convert to HD once off vasopressors. Meropenem dose adjustment for CRRT (per pharmacy). Target: neutral fluid balance.